Difference in values between reanalysed and ISR samples [Bioanalytics]

posted by Ken Peh – Malaysia, 2013-03-16 15:40 (4852 d 17:35 ago) – Posting: # 10206
Views: 5,079

Dear Cakhatri,

According to EMEA Guideline on Bioanalytical Method Validation (2011), the concentration obtained for the initial analysis and reanalysis should be within 20% of their mean for at least 67% of the repeats. Large differences between results may indicate analytical issues and should be investigated.

If I interpret the guideline correctly, as long as you have more than 67% of the repeats within 20% of their means, you are safe.

What do you mean when you mentioned "ISR passed with more than 95% acceptance criteria" ?

I have no experience dealing with FDA on ISR. Any guideline by FDA on this matter ??

Regards,
Ken

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
331 visitors (0 registered, 331 guests [including 16 identified bots]).
Forum time: 10:15 CEST (Europe/Vienna)

Most scientists today are devoid of ideas, full of fear, intent on
producing some paltry result so that they can add to the flood
of inane papers that now constitutes “scientific progress”
in many areas.    Paul Feyerabend

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5